Aniline hydroxylation in the human placenta--mechanistic aspects.
D000814:Aniline Compounds / Q000032:analysis / Q000378:metabolism*; D000818:Animals; D002417:Cattle; D003574:Cytochrome c Group / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D005260:Female; D006454:Hemoglobins / Q000008:administration & dosage / Q000378:metabolism; D006736:Horses; D006801:Humans; D006900:Hydroxylation; D066298:In Vitro Techniques; D007700:Kinetics; D006899:Mixed Function Oxygenases / Q000032:analysis / Q000037:antagonists & inhibitors; D008954:Models, Biological; D009243:NAD / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000494:pharmacology; D010920:Placenta / Q000201:enzymology / Q000378:metabolism*; D011247:Pregnancy; D051381:Rats; D014969:Xanthine Oxidase / Q000494:pharmacology
D000814:Aniline Compounds; D003574:Cytochrome c Group; D006454:Hemoglobins; D010714:Phosphatidylethanolamines; D009243:NAD; D009249:NADP; D006899:Mixed Function Oxygenases; D014969:Xanthine Oxidase